Jennifer Queally

Jennifer Queally, PhD

Assistant in Psychology

Instructor, Harvard Medical School

    Contact: 617-355-8434
  • Fax: 617-730-0319

Medical Services

Specialties

  • Neuropsychology

Departments

  • Psychiatry

Languages

  • English

Programs

  • Neuropsychology Program
  • Outpatient Psychiatry
  • Spina Bifida Center
To schedule an appointment: Call 617-355-8434

Experience and Education

Education

Undergraduate

George Washington University, 1998

Washington, DC

Graduate School

Suffolk University - Clinical Psychology, 2003

Boston, MA

Fellowship

Boston Children's Hospital - Pediatric Neuropsychology, 2003-2005

Boston, MA

Internship

Children's Hospitals and Clinics - Psychology, 2002-2003

Minneapolis, MN

Publications

Publications powered by Harvard Catalyst Profiles
  1. Hubert K, Sideridis G, Sherlock R, Queally J, Rosoklija I, Kringle G, Johnson K, Nurko S, Bauer S. Validation of a bowel dysfunction instrument for adolescents with spina bifida. J Pediatr Urol. 2015 Aug; 11(4):199.e1-7.
  2. Waber DP, Queally JT, Catania L, Robaey P, Romero I, Adams H, Alyman C, Jandet-Brunet C, Sallan SE, Silverman LB. Neuropsychological outcomes of standard risk and high risk patients treated for acute lymphoblastic leukemia on Dana-Farber ALL consortium protocol 95-01 at 5 years post-diagnosis. Pediatr Blood Cancer. 2012 May; 58(5):758-65.
  3. Mrakotsky CM, Silverman LB, Dahlberg SE, Alyman MC, Sands SA, Queally JT, Miller TP, Cranston A, Neuberg DS, Sallan SE, Waber DP. Neurobehavioral side effects of corticosteroids during active treatment for acute lymphoblastic leukemia in children are age-dependent: report from Dana-Farber Cancer Institute ALL Consortium Protocol 00-01. Pediatr Blood Cancer. 2011 Sep; 57(3):492-8.
  4. Waber DP, Turek J, Catania L, Stevenson K, Robaey P, Romero I, Adams H, Alyman C, Jandet-Brunet C, Neuberg DS, Sallan SE, Silverman LB. Neuropsychological outcomes from a randomized trial of triple intrathecal chemotherapy compared with 18 Gy cranial radiation as CNS treatment in acute lymphoblastic leukemia: findings from Dana-Farber Cancer Institute ALL Consortium Protocol 95-01. J Clin Oncol. 2007 Nov 01; 25(31):4914-21.
  5. Waber, D. P., Turek, J., Catania, L., Stevenson, K., Robaey, P., Romero, I., Adams, H., Alyman, C., Jandet-Brunet, C., Neuberg, D. S., Sallen, S. E., & Silverman, L. B. . Neuropsychological outcomes from a randomized trial of triple intrathecal chemotherapy therapy compared with 18 gray cranial radiation as CNS treatment in Acute Lymphoblastic Leukemia: Findings from Dana Farber Cancer Institute ALL Consortium Protocol 95-01. Journal of Clinical Oncology. 2007; 25(31):4914-4921.
To schedule an appointment: Call 617-355-8434

Locations

Boston Children’s is so much more than a hospital—it’s a community of researchers, clinicians, administrators, support staff, innovators, teachers, patients and families, all working together to make the impossible possible. ”
- Sandra L. Fenwick, President and CEO

Boston Children's Hospital
300 Longwood Avenue, Boston, MA 02115
For Patients: 617-355-6000
For Referring Providers: 844-BCH-PEDS | 844-224-7337

Close